Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days

Hellenic Journal of Cardiology

Volumn 52, Issue 3, 2011, Pages 227-235

  Aziz, Emad F ^a   Alviar, Carlos L ^a   Herzog, Eyal ^a   Cordova, Juan Pablo ^a   Bastawrose, Joseph H ^a   Pamidimukala, Chaithanya K ^a   Tojino, Andre ^a   Park, Terrence S ^a   Musat, Dan ^a   Kukin, Marrick ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Acute decompensated heart failure; Critical pathway; Diuretics in heart failure; Equal; Low dose dopamine

Indexed keywords

CREATINE KINASE MB; CREATININE; DOPAMINE; FUROSEMIDE; NATRIURETIC FACTOR; POTASSIUM; TROPONIN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; RETROSPECTIVE STUDY; SIDE EFFECT; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BLOOD UREA NITROGEN; CARDIOTONIC AGENTS; CREATININE; DIURETICS; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79959349845     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008; 168: 418-424.
2. American Heart Association. Heart Disease and Stroke Statistics: 2008 Update. Dallas, Tex: American Heart Association 2008.
3. Anand IS, Carson P, Galle E, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 2009; 119: 969-977.
4. Sauer WH, Bristow MR. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. J Interv Card Electrophysiol. 2008; 21: 3-11.
5. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest. 1990; 97: 1176-1180.
6. Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990; 18: 728-733.
7. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest. 1991; 100: 1068-1075.
8. Simmons RS, Berdine GG, Seidenfeld JJ, et al. Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis. 1987; 135: 924-929.
9. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis. 1992; 145: 990-998.
10. Schuller D, Schuster DP. Fluid management in acute respiratory distress syndrome. Curr Opin Crit Care. 1996; 2: 1-7.
11. Herzog E, Varley C, Kukin M. Pathway for the management of acute heart failure. Crit Pathw Cardiol. 2005; 4: 37-42.
12. Herzog E, Aziz E, Bangalore S, Varley C, Rozanski A, Kukin M. Translation of critical pathways for acute coronary syndrome and for acute heart failure into admission forms and discharge planning. Crit Pathw Cardiol. 2005; 4: 59-63.
13. title typecontributorGill RD. Multistate life-tables and regression models/title. Math Popul Stud. 1992; 3: 259-276.
14. Morgan K. Diverse factors influencing angiotensin metabo lism during ACE inhibition: insights from molecular biology and genetic studies. Br Heart J. 1994; 72: S3-10.
15. Rodeheffer RJRM. In: Murphy JG, editor. Congestive heart failure: diagnosis, evaluation, and surgical therapy. Mayo Clinic Cardiology Review. 2000; pp. 55-74.
16. Aziz EF, Herzog E, Djebali D, et al. Early diuretic administration combined with admission b-natriuretic peptide level are the strongest predictors of readmission at 30 days in patients treated for acute decompensated heart failure using a novel pathway. J Am Coll Cardiol. 2008; 51: A54.
17. Nelson GI, Silke B, Ahuja RC, Hussain M, Taylor SH. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet. 1983; 1: 730-733.
18. Hutcheon DE, Mehta D, Romano A. Diuretic action of furosemide. Arch Intern Med. 1965; 115: 542-546.
19. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973; 288: 1087-1090.
20. Benet LZ. Pharmacokinetics/pharmacodynamics of furosemide in man: a review. J Pharmacokinet Biopharm. 1979; 7: 1-27.
21. van Meyel JJ, Smits P, Russel FG, Gerlag PG, Tan Y, Gribnau FW. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther. 1992; 51: 440-444.
22. Pivac N, Rumboldt Z, Sardelić S, et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res. 1998; 18: 121-128.
23. Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996; 28: 376-382.
24. Copeland JG, Campbell DW, Plachetka JR, Salomon NW, Larson DF. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg. 1983; 146: 796-799.
25. Ostermann M, Alvarez G, Sharpe MD, Martin CM. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract. 2007; 107: c70-76.
26. Aaser E, Gullestad L, Tølløfsrud S, et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest. 1997; 57: 361-367.
27. Adin DB, Taylor AW, Hill RC, Scott KC, Martin FG. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med. 2003; 17: 632-636.
28. Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology (Carlton) 2008; 13: 247-250.
29. Schuller D, Lynch JP, Fine D. Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997; 25: 1969-1975.
30. Lahav M, Regev A, Ra'anani P, Theodor E. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest. 1992; 102: 725-731.
31. Mojtahedzadeh M, Salehifar E, Vazin A, et al. Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients. J Infus Nurs. 2004; 27: 255-261.
32. The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J. 1997; 18: 736-753.
33. Cody RJ, Ljungman S, Covit AB, et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 1988; 34: 361-367.
34. Brater DC. Resistance to loop diuretics. Why it happens and what to do about it. Drugs. 1985; 30: 427-443.
35. Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med. 1985; 102: 314-318.
36. Brater DC. Diuretic resistance: mechanisms and therapeutic strategies. Cardiology. 1994; 84 Suppl 2: 57-67.
37. Licata G, Di Pasquale P, Parrinello G, et al. Effects of highdose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003; 145: 459-466.
38. Riegger AJ. Neuroendocrine excitation in heart failure. Br Heart J. 1994; 72: S28-30.
39. Monteiro Pacheco A, Martins Coimbra RS, Kreimeier U, Frey L, Messmer K. Hypertonic volume therapy: feasibility in the prevention and treatment of multiple organ failure and sepsis. Sao Paulo Med J. 1995; 113: 1053-1060.
40. Oliva F, Latini R, Politi A, et al. Intermittent 6-month lowdose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J. 1999; 138(2 Pt 1): 247-253.
41. Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001; 29: 1526-1531.
42. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003; 123: 1266-1275.
43. Goldberg LI, McDonald RH, Zimmerman AM. Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med. 1963; 269: 1060-1064.
44. Beregovich J, Bianchi C, Rubler S, Lomnitz E, Cagin N, Levitt B. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J. 1974; 87: 550-557.
45. Lindner A. Synergism of dopamine and furosemide in diuretic- resistant, oliguric acute renal failure. Nephron. 1983; 33: 121-126.
46. Vargo DL, Brater DC, Rudy DW, Swan SK. Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. J Am Soc Nephrol. 1996; 7: 1032-1037.
47. Elkayam U, Ng TMH, Hatamizadeh P, Janmohamed M, Mehra A. Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation. 2008; 117: 200-205.
48. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997; 62: 187-193.